Melinda French Gates announced last week a historic $215 million commitment to women’s health, including a $10 million gift to the Menopause Society. It is a beautiful and necessary act of generosity.
It arrives on the same day a new Mayo Clinic study showing hormone therapy use among menopausal women has dropped to a historic low of 1.7 percent—even as evidence of its safety has grown.
We are moving backward and forward at the same time.
French Gates put a spotlight on the fact that women’s health has been inexcusably underfunded. The questions to add to that conversation: What would medicine look like if it saw menopause not as nature’s mistake, but as evolution’s investment? What would our economy look like? What would our communities look like? What problems might we finally solve?
The science exists. The economic case is clear. And the legislative momentum is building. What is missing is the cultural shift that allows medicine, policy and society to see post-menopausal women not as a problem to manage, but as a resource we cannot afford to waste.